Showing 351-360 of 2820 results for "".
Cannabinoids and the Endocannabinoid System: Emerging Trends
https://practicalneurology.com/diseases-diagnoses/headache-pain/cannabinoids-and-the-endocannabinoid-system-emerging-trends/30406/Cannabis-derived therapies may offer a great opportunity to modulate the endocannabinoid system, but understanding the risks is paramount.A Case of Adult-Onset Postviral Opsoclonus–Myoclonus Syndrome
https://practicalneurology.com/diseases-diagnoses/neuromuscular/a-case-of-adult-onset-postviral-opsoclonusmyoclonus-syndrome/37659/The authors present a rare case of adult-onset postviral opsoclonus–myoclonus syndrome which resulted in marked symptomatic improvement and a favorable outcome due to timely diagnosis and intervention.Oral Disease Modifying Therapy for MS: Important Considerations
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/oral-disease-modifying-therapy-for-ms-important-considerations/30827/The availability of an oral agent for MS may create a therapeutic dilemma for clinicians as they try to determine the role of new therapy in patient care.Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy
https://practicalneurology.com/diseases-diagnoses/neuromuscular/diagnosis-of-chronic-inflammatory-demyelinating-polyneuropathy/32112/Due to the heterogeneous presentation of this complex disease, diagnosis is not always straightforward, and proper interpretation of clinical and diagnostic data is crucial to avoid misdiagnosis.Case Report: Cyclophosphamide as Rescue Agent in Myasthenic Crisis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/case-report-cyclophosphamide-as-rescue-agent-in-myasthenic-crisis/30120/When patients are refractory to first-line treatments for myasthenic crisis, cyclophosphamide may have benefits and warrants further study.Movement Disorders Moment: Sleep-Related Movement Disorders—A Review
https://practicalneurology.com/diseases-diagnoses/movement-disorders/sleep-related-movement-disorders/39812/Sleep disorders presenting primarily as physical movements are divided into 2 major categories—parasomnias and sleep-related movement disorders—which differ substantially in clinical consequences and treatment modalities.Clinical Genetic Testing for Alzheimer Disease and Related Dementias
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-genetic-testing-for-alzheimer-disease-and-related-dementias/32139/Understanding the role of genetics in neurodegenerative dementia can help guide testing and improve clinical practice.Biomarkers in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/imaging-testing/biomarkers-in-multiple-sclerosis/30195/Biomarkers have resulted from breakthrough treatments and, in turn, provide targets for more breakthroughs.Diagnosis and Treatment of Neuro-Ophthalmologic Symptoms in People with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-treatment-of-neuro-ophthalmologic-symptoms-in-people-with-parkinson-disease/37656/Recognizing and addressing neuro-ophthalmologic signs and symptoms are essential for delivering comprehensive, patient-centered care and improving long-term outcomes in individuals with PD.Migraine Preventive Therapies in Development
https://practicalneurology.com/diseases-diagnoses/headache-pain/migraine-preventive-therapies-in-development/31512/The field of headache medicine is full of promise with more migraine-specific preventive therapies in development.